Latest News

In One Chart: Eli Lilly on track to close with a higher market cap than J&J for first time since 1997

Eli Lilly’s stock has benefited from positive data in trials of an obesity drug and a treatment for Alzheimer’s disease. 

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:Latest News